Elena Laserna

794 total citations
22 papers, 582 citations indexed

About

Elena Laserna is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology and Critical Care and Intensive Care Medicine. According to data from OpenAlex, Elena Laserna has authored 22 papers receiving a total of 582 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pulmonary and Respiratory Medicine, 9 papers in Epidemiology and 6 papers in Critical Care and Intensive Care Medicine. Recurrent topics in Elena Laserna's work include Pneumonia and Respiratory Infections (7 papers), Cystic Fibrosis Research Advances (7 papers) and Respiratory Support and Mechanisms (5 papers). Elena Laserna is often cited by papers focused on Pneumonia and Respiratory Infections (7 papers), Cystic Fibrosis Research Advances (7 papers) and Respiratory Support and Mechanisms (5 papers). Elena Laserna collaborates with scholars based in Spain, United States and United Kingdom. Elena Laserna's co-authors include Oriol Sibila, Remedios Otero, Fernando Uresandi, Dolores Nauffal, David Jiménez, Francisco Conget, Miguel Ángel Cabezudo, Marcos I. Restrepo, Antonio Anzueto and Eric M. Mortensen and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, CHEST Journal and European Respiratory Journal.

In The Last Decade

Elena Laserna

20 papers receiving 570 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elena Laserna Spain 14 245 234 229 158 121 22 582
M. Lugosi France 8 62 0.3× 144 0.6× 178 0.8× 57 0.4× 96 0.8× 13 500
Tomoyoshi Mohri Japan 9 69 0.3× 68 0.3× 223 1.0× 88 0.6× 121 1.0× 13 520
Celia Zamarro Spain 9 123 0.5× 196 0.8× 108 0.5× 147 0.9× 51 0.4× 12 381
H Verbruggen Netherlands 6 68 0.3× 125 0.5× 108 0.5× 86 0.5× 36 0.3× 14 362
Juan José Martín-Villasclaras Spain 10 159 0.6× 54 0.2× 348 1.5× 36 0.2× 121 1.0× 13 538
J.E. Guerrero Spain 11 148 0.6× 25 0.1× 270 1.2× 38 0.2× 62 0.5× 26 483
Aikaterini Konstantinidi Greece 17 270 1.1× 43 0.2× 250 1.1× 16 0.1× 288 2.4× 46 672
Müge Aydoğdu Türkiye 13 162 0.7× 29 0.1× 182 0.8× 24 0.2× 157 1.3× 47 511
Renee A. Higgerson United States 8 97 0.4× 63 0.3× 91 0.4× 25 0.2× 56 0.5× 9 312
Bashar Fahoum United States 9 185 0.8× 21 0.1× 65 0.3× 79 0.5× 28 0.2× 15 378

Countries citing papers authored by Elena Laserna

Since Specialization
Citations

This map shows the geographic impact of Elena Laserna's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elena Laserna with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elena Laserna more than expected).

Fields of papers citing papers by Elena Laserna

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elena Laserna. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elena Laserna. The network helps show where Elena Laserna may publish in the future.

Co-authorship network of co-authors of Elena Laserna

This figure shows the co-authorship network connecting the top 25 collaborators of Elena Laserna. A scholar is included among the top collaborators of Elena Laserna based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elena Laserna. Elena Laserna is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sibila, Oriol, Elena Laserna, Amelia Shoemark, et al.. (2021). Heterogeneity of treatment response in bronchiectasis clinical trials. European Respiratory Journal. 59(5). 2100777–2100777. 27 indexed citations
2.
Sibila, Oriol, Elena Laserna, Amelia Shoemark, et al.. (2020). Heterogeneity of treatment response in bronchiectasis clinical trials. 3332–3332. 1 indexed citations
3.
Sibila, Oriol, Elena Laserna, Amelia Shoemark, et al.. (2019). Airway Bacterial Load and Inhaled Antibiotic Response in Bronchiectasis. American Journal of Respiratory and Critical Care Medicine. 200(1). 33–41. 74 indexed citations
4.
Laserna, Elena, Amelia Shoemark, Holly R. Keir, et al.. (2019). Airway Bacterial Load and Response to Inhaled Aztreonam in Bronchiectasis. A5714–A5714. 1 indexed citations
5.
6.
Rodrigo‐Troyano, Ana, Pedro J. Marcos, Elena Laserna, et al.. (2018). <b><i>Pseudomonas aeruginosa</i></b> in Chronic Obstructive Pulmonary Disease Patients with Frequent Hospitalized Exacerbations: A Prospective Multicentre Study. Respiration. 96(5). 417–424. 39 indexed citations
7.
Laserna, Elena, Oriol Sibila, Juan F. Fernandez, et al.. (2014). Impact of Macrolide Therapy in Patients Hospitalized With Pseudomonas aeruginosa Community-Acquired Pneumonia. CHEST Journal. 145(5). 1114–1120. 16 indexed citations
8.
Sibila, Oriol, Eric M. Mortensen, Antonio Anzueto, Elena Laserna, & Marcos I. Restrepo. (2013). Prior cardiovascular disease increases long-term mortality in COPD patients with pneumonia. European Respiratory Journal. 43(1). 36–42. 24 indexed citations
9.
Sibila, Oriol, Elena Laserna, Eric M. Mortensen, Antonio Anzueto, & Marcos I. Restrepo. (2013). Effects of Inhaled Corticosteroids on Pneumonia Severity and Antimicrobial Resistance. Respiratory Care. 58(9). 1489–1494. 13 indexed citations
10.
Laserna, Elena, Oriol Sibila, Patrick R. Aguilar, et al.. (2012). Hypocapnia and Hypercapnia Are Predictors for ICU Admission and Mortality in Hospitalized Patients With Community-Acquired Pneumonia. CHEST Journal. 142(5). 1193–1199. 55 indexed citations
11.
Sibila, Oriol, et al.. (2012). Evaluation of the IDSA/ATS Minor Criteria for Severe Community-Acquired Pneumonia. Hospital Practice. 40(2). 158–164. 5 indexed citations
12.
Sibila, Oriol, G. Umberto Meduri, Eric M. Mortensen, et al.. (2012). Improving the 2007 Infectious Disease Society of America/American Thoracic Society severe community-acquired pneumonia criteria to predict intensive care unit admission. Journal of Critical Care. 28(3). 284–290. 14 indexed citations
13.
Laserna, Elena, Antonio Anzueto, Mary Bollinger, et al.. (2012). Understanding Hospital 30-Day Readmissions in Critical Care Survivors After Requiring Mechanical Ventilation. CHEST Journal. 142(4). 421A–421A.
14.
Laserna, Elena, et al.. (2012). Impact of prior systemic corticosteroid use in patients admitted with community-acquired pneumonia. Therapeutic Advances in Respiratory Disease. 6(6). 323–330. 4 indexed citations
15.
Uresandi, Fernando, Remedios Otero, Aurelio Cayuela, et al.. (2007). A Clinical Prediction Rule for Identifying Short-Term Risk of Adverse Events in Patients With Pulmonary Thromboembolism. Archivos de Bronconeumología. 43(11). 617–622. 35 indexed citations
16.
Jiménez, David, Roger D. Yusen, Remedios Otero, et al.. (2007). Prognostic Models for Selecting Patients With Acute Pulmonary Embolism for Initial Outpatient Therapy. CHEST Journal. 132(1). 24–30. 153 indexed citations
17.
Uresandi, Fernando, Remedios Otero, Aurelio Cayuela, et al.. (2007). Escala de riesgo de eventos adversos a corto plazo en pacientes con tromboembolia pulmonar. Archivos de Bronconeumología. 43(11). 617–622. 46 indexed citations
18.
Nauffal, Dolores, Aurelio Cayuela, Remedios Otero, et al.. (2006). Complicaciones precoces en pacientes con embolia de pulmón. Medicina Clínica. 127(1). 1–4. 4 indexed citations
19.
Laserna, Elena, et al.. (2003). Ventilación no invasiva en cifoescoliosis. Estudio comparativo entre respirador volumétrico y soporte de presión (BIPAP). Archivos de Bronconeumología. 39(1). 13–18. 15 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M. Lugosi Breakdown of academic impact, for papers by Tomoyoshi Mohri Breakdown of academic impact, for papers by Celia Zamarro Breakdown of academic impact, for papers by H Verbruggen Breakdown of academic impact, for papers by Juan José Martín-Villasclaras Breakdown of academic impact, for papers by J.E. Guerrero Breakdown of academic impact, for papers by Aikaterini Konstantinidi Breakdown of academic impact, for papers by Müge Aydoğdu Breakdown of academic impact, for papers by Renee A. Higgerson Breakdown of academic impact, for papers by Bashar Fahoum
Rankless by CCL
2026